In recent quarters, Duquesne has been selling AI winners like Nvidia (NASDAQ: NVDA) and Palantir Technologies (NASDAQ: PLTR) and piling into one of Wall Street's hottest drug stocks ahead of 2026.
Ken Griffin's fund, Citadel, is a "pod shop" in which the firm allocates capital to mini teams that have broad autonomy over ...
Duquesne Family Office's billionaire boss bid adieu to a "magnificent" stock and absolutely gobbled up shares of what had been a remarkably cheap media company.